Xience Prime Stent

NEW XIENCE SIERRA STENT DESIGN
The new XIENCE Sierra Stent Design, with Slim Flex Technology, has a lower crossing profile1 and greater post-dilatation expansion

NEW STENT DELIVERY SYSTEM FOR COMPLEX CASES
Design innovations built to provide the flexibility, crossability, and pushability needed for even the most complex cases.

The XIENCE V®, XIENCE nano®, XIENCE PRIME®, XIENCE PRIME® LL, XIENCE Xpedition®, XIENCE Xpedition® SV and XIENCE Xpedition® LL , XIENCE Alpine®, and XIENCE SierraTM (XIENCE Family) of Everolimus Eluting Coronary Stents on the MULTI-LINK VISION® or MULTI-LINK MINI VISION® Delivery System

INDICATIONS
The XIENCE Sierra stent system is indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions (length â?¤ 32 mm) with reference vessel diameters of â?¥ 2.25 mm to â?¤ 4.25 mm. In addition, the XIENCE Sierra stent system is indicated for treating de novo chronic total coronary occlusions.

CONTRAINDICATIONS
The XIENCE Sierra stent system is contraindicated for use in:

Patients who cannot tolerate, including allergy or hypersensitivity to, procedural anticoagulation or the post-procedural antiplatelet regimen.
Patients with hypersensitivity or contraindication to everolimus or structurally related compounds, or known hypersensitivity to stent components (cobalt, chromium, nickel, tungsten, acrylic, fluoropolymers), or with contrast sensitivity.
WARNINGS

It is not recommended to treat patients having a lesion that prevent complete inflation of an angioplasty balloon.
Judicious patient selection is necessary because the use of this device carries the associated risk of stent thrombosis, vascular complications, and/or bleeding events.
This product should not be used in patients who are not likely to comply with the recommended antiplatelet therapy.